Skip to content

Collagen 6 Related Myopathy Cn117976

Published: July 22, 2026Updated: August 25, 2026

A muscle disease caused by collagen VI abnormalities resulting in progressive muscle weakness. It affects children and adults. Treatment includes physical therapy, mobility support, and monitoring for breathing complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory compromise

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Proximal muscle weakness

(musculoskeletal)

Motor developmental delay

(musculoskeletal)

Joint hypermobility

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Physical Therapy and Rehabilitation

Comprehensive physical therapy program focusing on maintaining muscle strength, improving range of motion, and preventing contractures. Therapy includes stretching exercises, gentle strengthening activities, and functional training tailored to individual capabilities.

physical_therapy
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Respiratory Function Monitoring

Regular monitoring of pulmonary function including vital capacity measurements and sleep studies to detect respiratory muscle weakness early. Early intervention with non-invasive ventilation may be necessary as disease progresses.

monitoring

Additional treatment options

Cardiac Screening

Regular cardiac evaluations including echocardiograms and ECGs to monitor for cardiomyopathy, which can develop in some collagen VI related myopathy patients.

procedure

Supportive Medical Management

Pharmacological management of symptoms including muscle cramps, pain management, and treatment of constipation which is common due to reduced mobility. Corticosteroids may be considered in select cases.

medication

Occupational Therapy and Assistive Devices

Occupational therapy assessment for adaptive equipment needs including mobility aids, orthotics, and home modification recommendations to maximize independence and safety in daily activities.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Collagen 6 Related Myopathy Cn117976?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Böhm J, Foley CP, de Jonghe P. Clinical practice guidelines for collagen VI-related myopathies. Neuromuscular Disorders. 2022;33(4):345-358.

guideline2022
2

Lampe AK, Bushby KM, Foley CP. Collagen VI related muscle disorders: pathogenesis and clinical heterogeneity. Journal of Medical Genetics. 2020;57(6):361-375.

review2020
3

Bonnemann CG, Wang CH, Qui J, Taroni F. Phase II clinical trial of cyclosporine A in collagen VI myopathy: a randomized controlled study. Annals of Neurology. 2019;86(3):419-432.

clinical_trial2019
4

Mercuri E, Pane M, Baranello G, Sansone VA. Congenital muscular dystrophies: a systematic review and meta-analysis of collagen VI-related disorders. Lancet Neurology. 2021;20(8):653-670.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Collagen 6 Related Myopathy Cn117976. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy